← Medirom Healthcare Technologies Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $3.9b |
$3.3b
-14.50%
|
$5.4b
+61.89%
|
$7.0b
+28.54%
|
$6.8b
-1.81%
|
$8.3b
+21.55%
|
$8.1b
-2.79%
|
|
| Gain from sales of salons | — | — | — | — | $413.7m | $40.6m | — | |
| Cost of Goods and Services Sold | $3.0b |
$2.9b
-1.52%
|
$4.0b
+37.14%
|
$5.1b
+26.47%
|
$5.3b
+4.11%
|
$6.1b
+15.09%
|
$6.0b
-0.11%
|
|
| Cost of revenue | $3.0b |
$2.9b
-1.52%
|
$4.0b
+37.14%
|
$5.1b
+26.47%
|
$5.3b
+4.11%
|
$6.1b
+15.09%
|
$6.0b
-0.11%
|
|
| Total cost of revenues and operating expenses | $3.9b |
$4.1b
+5.52%
|
$5.9b
+43.86%
|
$6.9b
+16.61%
|
$7.2b
+5.29%
|
$8.3b
+15.20%
|
— | |
| Gross Profit (derived) | $950.8m |
$428.9m
-54.88%
|
$1.4b
+229.97%
|
$1.9b
+34.41%
|
$1.6b
-17.53%
|
$2.2b
+43.18%
|
$2.0b
-10.02%
|
|
| Selling, General and Administrative Expense | $871.9m | $1.1b | $1.8b | $1.8b | $2.0b | $2.2b | $2.2b | |
| Labor and Related Expense | — | — | — | — | — | $718.5m | — | |
| Amortization of Intangible Assets | $16.6m | $20.6m | $45.8m | $85.9m | $145.6m | $182.4m | — | |
| Operating Lease, Expense | — | — | — | — | — | $89.1m | — | |
| Operating Income (Loss) | $34.4m |
($746.1m)
-2272.02%
|
($470.6m)
+36.93%
|
$97.0m
+120.61%
|
($391.6m)
-503.83%
|
($18.1m)
+95.38%
|
($111.0m)
-513.00%
|
|
| Investment Income, Interest | $1.3m | $1.3m | $839k | $6.1m | $1.1m | $8k | — | |
| Interest income | $1.3m | $1.3m | $839k | $6.1m | $1.1m | $8k | $57k | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | $15.0m | $14.8m | $26.8m | $18.1m | — | |
| Income (Loss) from Equity Method Investments | $559k | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | $4.2m | $19.7m | $24.4m | $51.1m | ($13.9m) | $42.9m | — | |
| Interest Expense (non-operating) | $13.6m | $13.2m | $11.9m | $9.8m | $36.9m | $49.7m | $55.1m | |
| Nonoperating Income (Expense) | ($1.6m) | $119.4m | $56.1m | $82.8m | $412.2m | $65.8m | — | |
| Total other income | ($1.6m) | $119.4m | $56.1m | $82.8m | $412.2m | $65.8m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $32.7m | ($626.7m) | ($414.5m) | $179.8m | $20.6m | $47.7m | ($58.4m) | |
| Current Income Tax Expense (Benefit) | $10.2m | $19.7m | $24.8m | $30.8m | $7.2m | $98.2m | ($94.0m) | |
| Income tax (benefit) expense | $16.0m | ($87.5m) | $576.2m | $30.8m | ($94.4m) | ($90.5m) | — | |
| Net Income (Loss) Attributable to Parent | $17.3m |
($539.2m)
-3210.30%
|
($990.7m)
-83.75%
|
$149.0m
+115.04%
|
$115.4m
-22.53%
|
$148.8m
+28.91%
|
$40.5m
-72.79%
|
|
| Less: Net loss attributable to noncontrolling interests | — | — | — | — | $355k | ($10.6m) | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | ($355k) | — | $40.5m | |
| Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest | — | — | — | — | — | ($10.6m) | $40.5m | |
| Earnings Per Share, Basic | $4.63 | ($133.97) | ($203.13) | $30.54 | $23.64 | $29.13 | $29.13 | |
| Earnings Per Share, Diluted | $4.06 | ($133.97) | ($203.13) | $27.23 | $22.34 | $28.52 | $28.52 | |
| Weighted Average Number of Shares Outstanding, Basic | 3.7m | 4.0m | 4.9m | 4.9m | 4.9m | 5.1m | 5.1m | |
| Weighted Average Number of Shares Outstanding, Diluted | 4.3m | 4.0m | 4.9m | 5.5m | 5.2m | 5.9m | 5.9m | |
| Additional Financial Items | ||||||||
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | $10.5m | — | — | — | — | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | $0 | $107.5m | |
| Impairment loss on long-lived assets | $44.5m | $106.5m | $63.2m | $0 | $0 | $22.9m | — | |
| Dividend income | $2k | $2k | $2k | $2k | $2k | $2k | — | |
| Subsidies | — | $111.6m | $27.8m | $20.6m | $21.4m | $13.9m | — | |
| Foreign currency exchange gain | — | — | $15.0m | $14.8m | $26.8m | $18.1m | — | |
| Other, net | $4.2m | $19.7m | $24.4m | $51.1m | ($13.9m) | $42.9m | — | |
| Costs and Expenses | $3.9b | $4.1b | $5.9b | $6.9b | $7.2b | $8.3b | — | |
| Selling Expense | — | — | — | — | — | $181.2m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.